U.S. Physical Therapy price target raised to $110 from $107 at Barrington

Barrington raised the firm’s price target on U.S. Physical Therapy to $110 from $107 and keeps an Outperform rating on the shares following the Q4 results. Management commentary seemed to indicate an increasing focus on securing better pricing, with some conviction that the company has been making material progress with several commercial customers, the analyst tells investors in a research note. The firm views this as good news.